Determinants of Non-Participation in Population-Based Breast Cancer Screening: A Systematic Review and Meta-Analysis.
breast cancer
determinant
mammography
mass screening
participation
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
17
11
2021
accepted:
09
02
2022
entrez:
21
3
2022
pubmed:
22
3
2022
medline:
22
3
2022
Statut:
epublish
Résumé
Breast cancer (BC) screening can be performed in a screening program (BCSP) or in opportunistic screening. The existing reviews on the determinants of non-participation depend on self-reported data which may be biased. Furthermore, no distinction was made between the probably different determinants of both screening strategies. To find the determinants of non-participation in BCSP by means of a meta-analysis. PubMed, Embase, and Web of Science were searched for observational studies which quantified factors associated with non-participation in BCSP in a general population. Studies on opportunistic screening and studies using self-reported data were excluded. A random-effect model was used to calculate pooled odds ratios (ORs) and 95% confidence intervals (CIs). Potential sources of heterogeneity were explored by stratification of the results. Twenty-nine studies with in a total of 20,361,756 women were included. Low income (OR: 1.20, 95% CI: 1.10-1.30), low education (OR: 1.18, 95% CI: 1.05-1.32), living far from an assigned screening unit (OR: 1.15, 95% CI: 1.07-1.24), being immigrant (OR: 2.64, 95% CI: 2.48-2.82), and having a male family doctor (OR: 1.43, 95% CI: 1.20-1.61) was associated with higher non-participation in screening. Reminders sent to non-attenders and estimations of ORs (adjusted or not) partly explained substantial heterogeneity. In this meta-analysis excluding studies on the non-participation in opportunistic screening, or with self-reported data on non-participation, the well-known determinants for non-participation are still significant, but less strong. This analysis only supports the relevance of meta-analysis of studies with registered non-participation in a BCSP. PROSPERO, CRD42020154016.
Sections du résumé
Background
UNASSIGNED
Breast cancer (BC) screening can be performed in a screening program (BCSP) or in opportunistic screening. The existing reviews on the determinants of non-participation depend on self-reported data which may be biased. Furthermore, no distinction was made between the probably different determinants of both screening strategies.
Objective
UNASSIGNED
To find the determinants of non-participation in BCSP by means of a meta-analysis.
Methods
UNASSIGNED
PubMed, Embase, and Web of Science were searched for observational studies which quantified factors associated with non-participation in BCSP in a general population. Studies on opportunistic screening and studies using self-reported data were excluded. A random-effect model was used to calculate pooled odds ratios (ORs) and 95% confidence intervals (CIs). Potential sources of heterogeneity were explored by stratification of the results.
Results
UNASSIGNED
Twenty-nine studies with in a total of 20,361,756 women were included. Low income (OR: 1.20, 95% CI: 1.10-1.30), low education (OR: 1.18, 95% CI: 1.05-1.32), living far from an assigned screening unit (OR: 1.15, 95% CI: 1.07-1.24), being immigrant (OR: 2.64, 95% CI: 2.48-2.82), and having a male family doctor (OR: 1.43, 95% CI: 1.20-1.61) was associated with higher non-participation in screening. Reminders sent to non-attenders and estimations of ORs (adjusted or not) partly explained substantial heterogeneity.
Conclusion
UNASSIGNED
In this meta-analysis excluding studies on the non-participation in opportunistic screening, or with self-reported data on non-participation, the well-known determinants for non-participation are still significant, but less strong. This analysis only supports the relevance of meta-analysis of studies with registered non-participation in a BCSP.
Systematic Review Registration
UNASSIGNED
PROSPERO, CRD42020154016.
Identifiants
pubmed: 35311110
doi: 10.3389/fonc.2022.817222
pmc: PMC8924365
doi:
Types de publication
Systematic Review
Langues
eng
Pagination
817222Informations de copyright
Copyright © 2022 Ding, Wang, Greuter, Goossens, Van Hal and de Bock.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Rural Remote Health. 2014;14(2):2730
pubmed: 24953122
Clin Interv Aging. 2018 Oct 12;13:1987-1997
pubmed: 30349218
Acta Radiol. 2018 Nov;59(11):1285-1291
pubmed: 29451023
BMC Cancer. 2011 Aug 25;11:376
pubmed: 21867544
J Med Screen. 2012;19 Suppl 1:72-82
pubmed: 22972813
BMC Health Serv Res. 2010 Apr 27;10:103
pubmed: 20423467
J Public Health (Oxf). 2016 Jun;38(2):335-42
pubmed: 25922368
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
J Womens Health (Larchmt). 2008 Nov;17(9):1477-98
pubmed: 18954237
BMC Public Health. 2010 Mar 25;10:157
pubmed: 20334699
Prev Med. 2014 Jun;63:103-8
pubmed: 24345603
Cancer Epidemiol. 2010 Jun;34(3):309-15
pubmed: 20403737
Int J Equity Health. 2015 Dec 30;14:157
pubmed: 26715453
J Natl Cancer Inst. 2012 Jul 18;104(14):1080-93
pubmed: 22811439
BMC Cancer. 2015 Apr 17;15:294
pubmed: 25880028
Prev Med. 2015 Dec;81:392-8
pubmed: 26494608
Womens Health Issues. 2018 Jan - Feb;28(1):42-50
pubmed: 29174212
Int J Epidemiol. 2016 Aug;45(4):1169-1206
pubmed: 27272181
BMC Cancer. 2016 Oct 21;16(1):819
pubmed: 27769213
Prev Med Rep. 2017 Mar 23;6:214-220
pubmed: 28377847
Ann Oncol. 2008 Apr;19(4):614-22
pubmed: 18024988
Prev Med. 2015 Dec;81:281-9
pubmed: 26408405
BMJ Open. 2014 Oct 16;4(10):e005586
pubmed: 25324320
Cancer. 2020 Apr 1;126(7):1522-1529
pubmed: 31904881
Cancer Epidemiol Biomarkers Prev. 1998 Aug;7(8):681-7
pubmed: 9718220
Prev Med. 2017 Jul;100:84-88
pubmed: 28408217
BMC Public Health. 2015 Jul 21;15:679
pubmed: 26194189
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Cancer Causes Control. 2009 Feb;20(1):1-13
pubmed: 18802779
BMC Womens Health. 2014 Feb 10;14:24
pubmed: 24507093
Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):748-57
pubmed: 18381468
BMC Cancer. 2015 Oct 26;15:798
pubmed: 26502879
Asian Pac J Cancer Prev. 2012;13(1):147-55
pubmed: 22502658
JAMA. 2015 Oct 20;314(15):1615-34
pubmed: 26501537
Cancer Med. 2018 Aug;7(8):4044-4067
pubmed: 29984906
BMC Cancer. 2012 Nov 14;12:518
pubmed: 23151053
Health Psychol Rev. 2015;9(1):42-62
pubmed: 25793490
Prev Med Rep. 2018 Oct 27;12:349-354
pubmed: 30450274
BMC Health Serv Res. 2016 Sep 23;16(1):519
pubmed: 27663642
BMJ Open. 2016 Dec 8;6(12):e011458
pubmed: 27932337
BMC Cancer. 2012 Jun 18;12:254
pubmed: 22708828
J Am Coll Radiol. 2019 Apr;16(4 Pt B):570-579
pubmed: 30947889
N Engl J Med. 2015 Jun 11;372(24):2353-8
pubmed: 26039523
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Arch Womens Ment Health. 2011 Apr;14(2):159-68
pubmed: 21311925
Rev Epidemiol Sante Publique. 2012 Dec;60(6):421-30
pubmed: 23146369
Am J Prev Med. 1998 Jan;14(1):64-70
pubmed: 9476837
BMC Med Res Methodol. 2012 Apr 25;12:59
pubmed: 22533666
Cancer Epidemiol. 2017 Apr;47:7-19
pubmed: 28086199
Cancer Epidemiol. 2019 Jun;60:77-85
pubmed: 30927689
Eur J Cancer Prev. 2010 May;19(3):195-8
pubmed: 20150815
J Epidemiol Community Health. 2013 Oct;67(10):861-7
pubmed: 23851149
Clin Epidemiol. 2020 May 25;12:509-518
pubmed: 32547242